<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28220872</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2017</Year><Month>Feb</Month><Day>21</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Human enterovirus 71 protein interaction network prompts antiviral drug repositioning.</ArticleTitle><Pagination><StartPage>43143</StartPage><MedlinePgn>43143</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">43143</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep43143</ELocationID><Abstract><AbstractText>As a predominant cause of human hand, foot, and mouth disease, enterovirus 71 (EV71) infection may lead to serious diseases and result in severe consequences that threaten public health and cause widespread panic. Although the systematic identification of physical interactions between viral proteins and host proteins provides initial information for the recognition of the cellular mechanism involved in viral infection and the development of new therapies, EV71-host protein interactions have not been explored. Here, we identified interactions between EV71 proteins and host cellular proteins and confirmed the functional relationships of EV71-interacting proteins (EIPs) with virus proliferation and infection by integrating a human protein interaction network and by functional annotation. We found that most EIPs had known interactions with other viruses. We also predicted ATP6V0C as a broad-spectrum essential host factor and validated its essentiality for EV71 infection in vitro. EIPs and their interacting proteins were more likely to be targets of anti-inflammatory and neurological drugs, indicating their potential to serve as host-oriented antiviral targets. Thus, we used a connectivity map to find drugs that inhibited EIP expression. We predicted tanespimycin as a candidate and demonstrated its antiviral efficiency in vitro. These findings provide the first systematic identification of EV71-host protein interactions, an analysis of EIP protein characteristics and a demonstration of their value in developing host-oriented antiviral therapies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Traditional Chinese Medicine and Neuroimmunopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Kang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Chaozhi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Radiation Medicine, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qingjun</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qiling</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Qiyue</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bo</LastName><ForeName>Xiaochen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shengqi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing 100850, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="Y">Protein Interaction Maps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28220872</ArticleId><ArticleId IdType="pmc">PMC5318855</ArticleId><ArticleId IdType="doi">10.1038/srep43143</ArticleId><ArticleId IdType="pii">srep43143</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T. et al.. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10, 778&#x2013;790 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa M. J., Krishnan S., Tio P. H., Perera D. &amp; Wong S. C. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet 354, 987&#x2013;991 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10501361</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M. et al.. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341, 929&#x2013;935 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L. G. et al.. Deaths of Children during an Outbreak of Hand, Foot, and Mouth Disease in Sarawak, Malaysia: Clinical and Pathological Characteristics of the Disease. Clin. Infect. Dis. 31, 678&#x2013;683 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong C. Y. et al.. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatr. Oslo Nor. 1992 92, 1163&#x2013;1169 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14632332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F. et al.. Enterovirus 71 outbreak in the People&#x2019;s Republic of China in 2008. J. Clin. Microbiol. 47, 2351&#x2013;2352 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B. A., Oberste M. S., Alexander J. P., Kennett M. L. &amp; Pallansch M. A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 73, 9969&#x2013;9975 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez-Rios J. &amp; Uetz P. Global approaches to study protein-protein interactions among viruses and hosts. Future Microbiol 5, 289&#x2013;301 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2832059</ArticleId><ArticleId IdType="pubmed">20143950</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan S.-L., Ganji G., Paeper B., Proll S. &amp; Katze M. G. Systems biology and the host response to viral infection. Nat. Biotechnol. 25, 1383&#x2013;1389 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097743</ArticleId><ArticleId IdType="pubmed">18066032</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal M. &amp; Fields S. The yeast two-hybrid assay: still finding connections after 25 years. Nat. Methods 11, 1203&#x2013;1206 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25584376</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozenblatt-Rosen O. et al.. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 487, 491&#x2013;495 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408847</ArticleId><ArticleId IdType="pubmed">22810586</ArticleId></ArticleIdList></Reference><Reference><Citation>Uetz P. et al.. Herpesviral Protein Networks and Their Interaction with the Human Proteome. Science 311, 239&#x2013;242 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16339411</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman B. T. &amp; Lempicki R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1&#x2013;13 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615629</ArticleId><ArticleId IdType="pubmed">19033363</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Wei Huang B. T. S. &amp; Lempicki R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44&#x2013;57 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatr-Aryamontri A. et al.. The BioGRID interaction database: 2015 update. Nucleic Acids Res. 43, D470&#x2013;478 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383984</ArticleId><ArticleId IdType="pubmed">25428363</ArticleId></ArticleIdList></Reference><Reference><Citation>Croft D. et al.. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. gkq1018, doi: 10.1093/nar/gkq1018 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq1018</ArticleId><ArticleId IdType="pmc">PMC3013646</ArticleId><ArticleId IdType="pubmed">21067998</ArticleId></ArticleIdList></Reference><Reference><Citation>Vastrik I. et al.. Reactome: a knowledge base of biologic pathways and processes. Genome Biol. 8, R39 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868929</ArticleId><ArticleId IdType="pubmed">17367534</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout A. J. M. &amp; Vidal M. High-Throughput Yeast Two-Hybrid Assays for Large-Scale Protein Interaction Mapping. Methods 24, 297&#x2013;306 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11403578</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlas A. et al.. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463, 818&#x2013;822 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20081832</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y. et al.. EHFPI: a database and analysis resource of essential host factors for pathogenic infection. Nucleic Acids Res. 43, D946&#x2013;955 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383917</ArticleId><ArticleId IdType="pubmed">25414353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb J. et al.. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929&#x2013;1935 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17008526</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb J. The Connectivity Map: a new tool for biomedical research. Nat. Rev. Cancer 7, 54&#x2013;60 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17186018</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A. et al.. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545&#x2013;15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Doedens J. R. &amp; Kirkegaard K. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 14, 894&#x2013;907 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC398162</ArticleId><ArticleId IdType="pubmed">7889939</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderwood M. A. et al.. Epstein&#x2013;Barr virus and virus human protein interaction maps. Proc. Natl. Acad. Sci. 104, 7606&#x2013;7611 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1863443</ArticleId><ArticleId IdType="pubmed">17446270</ArticleId></ArticleIdList></Reference><Reference><Citation>de Chassey B. et al.. Hepatitis C virus infection protein network. Mol. Syst. Biol. 4, Article number 230 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2600670</ArticleId><ArticleId IdType="pubmed">18985028</ArticleId></ArticleIdList></Reference><Reference><Citation>Konig R. et al.. Human Host Factors Required for Influenza Virus Replication. Nature 463, 813&#x2013;817 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2862546</ArticleId><ArticleId IdType="pubmed">20027183</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavelin J. et al.. Systematic MicroRNA Analysis Identifies ATP6V0C as an Essential Host Factor for Human Cytomegalovirus Replication. PLOS Pathog 9, e1003820 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3873435</ArticleId><ArticleId IdType="pubmed">24385903</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan M. N. et al.. RNA interference screen for human genes associated with West Nile virus infection. Nature 455, 242&#x2013;245 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3136529</ArticleId><ArticleId IdType="pubmed">18690214</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco L., Otero M. J. &amp; Castrillo J. Modification of membrane permeability by animal viruses. Pharmacol. Ther. 40, 171&#x2013;212 (1989).</Citation><ArticleIdList><ArticleId IdType="pubmed">2499894</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt S. R., Hernandez R. &amp; Brown D. T. Role of the Vacuolar-ATPase in Sindbis Virus Infection. J. Virol. 85, 1257&#x2013;1266 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3020509</ArticleId><ArticleId IdType="pubmed">21084471</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavassoli A. Targeting the protein &#x2013; protein interactions of the HIV lifecycle. Chem. Soc. Rev. 40, 1337&#x2013;1346 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21152581</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Duan W. &amp; Tan S.-L. Emerging host cell targets for hepatitis C therapy. Drug Discov. Today 12, 209&#x2013;217 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17331885</ArticleId></ArticleIdList></Reference><Reference><Citation>de Chassey B., Meyniel-Schicklin L., Aublin-Gex A., Andr&#xe9; P. &amp; Lotteau V. New horizons for antiviral drug discovery from virus&#x2013;host protein interaction networks. Curr. Opin. Virol. 2, 606&#x2013;613 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23025912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessions O. M. et al.. Discovery of insect and human dengue virus host factors. Nature 458, 1047&#x2013;1050 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3462662</ArticleId><ArticleId IdType="pubmed">19396146</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfefferle S. et al.. The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors. PLoS Pathog. 7, e1002331 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203193</ArticleId><ArticleId IdType="pubmed">22046132</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma-Lauer Y., Lei J., Hilgenfeld R. &amp; von Brunn A. Virus&#x2013;host interactomes &#x2014; antiviral drug discovery. Curr. Opin. Virol. 2, 614&#x2013;621 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102765</ArticleId><ArticleId IdType="pubmed">23057872</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisel M. B., Crouchet E., Baumert T. F. &amp; Schuster C. Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection. Viruses 7, 5659&#x2013;5685 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4664971</ArticleId><ArticleId IdType="pubmed">26540069</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe M. K. et al.. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target. Antiviral Res. 130, 81&#x2013;92 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4955699</ArticleId><ArticleId IdType="pubmed">27058774</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis G. et al.. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, R60 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12734009</ArticleId></ArticleIdList></Reference><Reference><Citation>Law V. et al.. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091&#x2013;D1097 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3965102</ArticleId><ArticleId IdType="pubmed">24203711</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey F. J. The Kolmogorov-Smirnov Test for Goodness of Fit. J. Am. Stat. Assoc. 46, 68&#x2013;78 (1951).</Citation></Reference><Reference><Citation>Liu J. et al.. In vitro and in vivo protection against enterovirus 71 by an antisense phosphorothioate oligonucleotide. Arch. Virol. 159, 2339&#x2013;2347 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24756344</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>